Munich, November 11, 2019: inCare, the digital health company developing digital therapies, announced that it is participating and presenting at the BIO-EUROPE 2019 in Hamburg.
The BIO-EUROPE is being held from November 11 to 12, 2019 in Hamburg, Germany and is an international forum to promote business development between pharmaceutical, financial and biotechnology companies. The event is Europe’s largest partnering conference serving the global biotech industry. At this conference leading decision makers of the biotechnology, pharmaceutical and financial industry employed at emerging companies meet annually. Investors and pharmaceutical companies offer benefits to life-science companies that exceed financial investment. These benefits include information on questions reaching from regulatory and permit requirements to marketing and representations of interests for patients.
inCare is presenting its latest advancements in digital therapies and will give a future outlook on new development programs.
inCare is offering digital therapies alongside pharmacological products to address improvement in personalization, adherence and behavior mediated indications.
The awarded applications are offering potential for increased drug compliance in combination with direct and earlier patient engagement by combining drugs, mobile applications, wearables and artificial intelligence technologies in a digital therapy platform for drug personalization and adherence improvement.
We are transforming care by extending digital health beyond activity monitoring and offering deeper insights about patient health patterns and medication treatment effectiveness, leading to more informed healthcare decisions and better outcomes for everyone involved.